key: cord-0952124-qedry34t
authors: Preiser, Jean-Charles; Arabi, Yaseen M.; Berger, Mette M.; Casaer, Michael; McClave, Stephen; Montejo-González, Juan C.; Peake, Sandra; Reintam Blaser, Annika; Van den Berghe, Greet; van Zanten, Arthur; Wernerman, Jan; Wischmeyer, Paul
title: A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice
date: 2021-12-14
journal: Crit Care
DOI: 10.1186/s13054-021-03847-4
sha: 99c64c08a11009aae4c4c6cdb4b25de164d41283
doc_id: 952124
cord_uid: qedry34t

The preferential use of the oral/enteral route in critically ill patients over gut rest is uniformly recommended and applied. This article provides practical guidance on enteral nutrition in compliance with recent American and European guidelines. Low-dose enteral nutrition can be safely started within 48 h after admission, even during treatment with small or moderate doses of vasopressor agents. A percutaneous access should be used when enteral nutrition is anticipated for ≥ 4 weeks. Energy delivery should not be calculated to match energy expenditure before day 4–7, and the use of energy-dense formulas can be restricted to cases of inability to tolerate full-volume isocaloric enteral nutrition or to patients who require fluid restriction. Low-dose protein (max 0.8 g/kg/day) can be provided during the early phase of critical illness, while a protein target of > 1.2 g/kg/day could be considered during the rehabilitation phase. The occurrence of refeeding syndrome should be assessed by daily measurement of plasma phosphate, and a phosphate drop of 30% should be managed by reduction of enteral feeding rate and high-dose thiamine. Vomiting and increased gastric residual volume may indicate gastric intolerance, while sudden abdominal pain, distension, gastrointestinal paralysis, or rising abdominal pressure may indicate lower gastrointestinal intolerance.

The importance of nutrition in the critically ill is increasingly acknowledged, especially in patients with long stay in the intensive care unit (ICU), who often require prolonged life-sustaining support and go through a state of severe catabolism [1, 2] . Some aspects of the nutrition practice such as the preferential use of the early oral/ enteral nutrition (EN) over «gut rest» and the acceptance of delaying provision of amounts of nutrients calculated to match the losses and expenditure, while other aspects can raise controversial views [3] [4] [5] .

International guidelines have been recently updated by the American Society of Parenteral and Enteral Nutrition/Society of Critical Care Medicine [6] and the European Society of Clinical Nutrition and Metabolism (ESPEN) [2, 7] , with various levels of supporting evidence (Table 1) . A group of experts in critical care nutrition from different regions of the world was commissioned to discuss some of the practicalities of early EN, listed in Table 1 and supported in the corresponding sections, to use and to complement the guidelines [6, 7] by providing tips inspired by the current knowledge and clinical experience of the experts. Importantly, nutritional requirements will vary according to the phase of critical illness, our tips are general in nature, and an individualized approach should always be used.

*Correspondence: jean-charles.preiser@erasme.ulb.ac.be 1 Erasme University Hospital, Université Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium Full list of author information is available at the end of the article Critically illness induces a cascade of metabolic and hormonal derangements, leading to severe macro-and micronutrient deficiencies [8] . The provision of exogenous nutrients via early commencement of EN helps mitigate this catabolic state and prevent intestinal villi atrophy, enterocyte apoptosis, inflammatory infiltration, dysbiosis and impairment of gut immune functions [9] . Early EN may alleviate or even reverse some of these pathophysiologic cascades [10] [11] [12] . Clinical data have also supported early EN (within 24-48 h of ICU admission) in critically ill patients. Multiple meta-analyses of randomized controlled trials showed that early EN compared to late EN was associated with reduced infectious morbidity in ICU patients [5, 6, 13] . However, several of the studies were of small sample sizes, and some were conducted more than 3 decades ago, with different standards of ICU management and nutritional therapy. Additionally, some of the older trials have important methodological limitations questioning their internal validity including selection bias, frequent postrandomization exclusions and lack of adherence to the intentionto-treat principle. A recent Cochrane meta-analysis assessed current evidence to be of very low quality, leading to uncertainty as to whether early EN, compared with delayed EN, affects the risk of mortality, feed intolerance or gastrointestinal complications, or pneumonia [14] .

In spite of the low level of evidence, recent guidelines [6, 7] recommend the commencement of low-dose EN within 24-48 h of critical illness in the majority of ICU patients.

Patients receiving vasopressor agents represent a special group, in which the potential benefit of early EN should be balanced against the associated risk [15] [16] [17] . Some data suggest that trickle feeding is possible even with high dose norepinephrine [18] . Data regarding the clinical benefits and risks of early EN in patients on vasopressor agents are limited. Although several observational data described an association between early EN and bowel ischemia, establishing causality between vasopressor agents and bowel ischemia in these studies is difficult [19] [20] [21] . In the NUTRIREA-2 trial, adults receiving mechanical ventilation and vasopressor agents were randomized to either early parenteral nutrition (PN) or EN, both at rates calculated to match the energy expenditure [22] . The study found no difference in the primary endpoint of 28-day mortality, but demonstrated a fourfold increase in bowel ischemia and acute colonic pseudoobstruction with early EN [22] . The study suggests that full dose EN should be postponed until hemodynamic stability is restored. Whether lower amounts of EN or no EN at all would be the best option in patients with severe shock is not known. Still, aggregated data from 11 randomized controlled trials (RCTs, n = 597) show that early EN might decrease infectious complications [14] presumably via the protection of gastrointestinal wall integrity [23] . Nevertheless, in NUTRIREA-2 (N = 2410) and CALORIES (N = 2400), early EN as compared to PN for no more than 3-5 days did not decrease the infection rate [22, 24] .

Several related questions are currently subject to ongoing research including comparing early trophic EN with no EN in the first 24 h [25] [26] [27] [28] [29] .

Given the existing data, low-dose EN is recommended within 48 h of ICU admission, in patients with controlled shock requiring small or moderate doses of vasopressor and delaying EN in patients who are actively being resuscitated or are unstable [5, 6] . In patients requiring vasopressors, EN should be started with gradual advancement, with monitoring for symptoms and signs of gastrointestinal intolerance or unexplained worsening hemodynamic status.

Decisions regarding enteral access are often determined by local expertise, anticipated duration of feeding, and evidence of gastroparesis or impaired gastrointestinal transit [30] .

Short-term feeding may be facilitated by blind bedside placement of a nasogastric tube. Reliable aids to confirm location within the stomach include an abdominal radiograph, continuous CO2 monitor, or differential esophageal/tracheal compliance to intermittent suction [30] .

The decision to switch from gastric to postpyloric feeding is based on perceived intolerance or delayed gastric emptying [7] . The placement of a postpyloric tube can be achieved endoscopic techniques, blind corkscrew technique, or GPS-guided or optically-guided tubes [30] . Use of a magnet-directed or flanged Tiger tube should be avoided. Surgical or radiologic techniques require transport to the operating room or radiologic suite, respectively. Randomized trials show a switch to postpyloric feeding reduces pneumonia significantly, but arguably no other outcome benefits are incurred, thereby underlying controversial views [6, 31, 32] . The decision to switch from nasoenteric to percutaneous access is predicated on an anticipated duration of feeding of greater than four weeks. A size of percutaneous endoscopic gastrostomy (PEG) tube larger than 18-20 French should be avoided, as torsion on the side wall leading to enlarged stomal diameter is more likely. Surgical placement of a gastrostomy tube is preferred in the presence of ascites, excluded stomach following bariatric surgery, or altered postoperative anatomy. Radiologic placement of a gastrostomy tube utilizes a variant of the "Introducer" technique.

The decision to attain deep jejunal access, such as converting a PEG to a PEGJ, is based on evidence of delayed gastric emptying [30, 33] . A new PEG can be converted even at initial placement by shortening the length of the PEG and placing a second smaller jejunostomy tube (J-tube) through the PEG into the small bowel. A mature tract (> 7-10 days since initial placement) is required to place a one-piece PEGJ, which affords a larger lumen for both feeding and aspiration.

The concept of high enteral energy intake has been postulated and tested, but this strategy failed to improve vital -and long-term functional [34] [35] [36] outcome in large-scale RCT's [37] [38] [39] [40] . These results suggest that disease-related anorexia contributes less to preventing lean-tissue wasting early in critical illness, than inflammation and mobilization. In some ICU patients, early up to target EN may moreover provoke harm. In patients recovering from circulatory shock, it provoked a small but significant increase in potentially lethal ischemic bowel complications [22] . Following a transitory decrease in serum phosphate, a feeding strategy aiming to achieve nutritional target increased mortality as compared to early nutrient restriction [41] (Question 9). Based on lack of benefit in large heterogeneous populations and signals of harm in some studies, ESPEN guidelines advise against early rapid advancement of feeding to target EN [7] .

The individualization of intakes rather than aiming for enhanced or more restrictive feeding, equally applied to all patients might physiologically make more sense. Several scores-integrating clinical characteristics upon ICU admission and/or biomarkers-have been constructed in order to identify patients who might benefit from earlier or enhanced nutrition support. In particular, the value of the NUTRIC (The Nutrition Risk in the Critically Ill) score appeared promising for that purpose in observational analyses [42] , but was refuted in stratified subanalysis of the PERMIT-RCT [43] . Indirect calorimetry (IC) provides accurate estimation of energy burned by patients at rest [7] . IC-guided nutrition therapy, however, did not convincingly improve outcomes, in the absence of methodologically sound evidence [44] [45] [46] [47] . The individualization of feeding based on a biomarker is not yet validated [48, 49] .

While the impact of early nutrition interventions in ICU appears to be limited, nutrient provision during in-ICU rehabilitation and after ICU discharge is unexplored and potentially relevant to functional recovery [1, 50, 51] .

In summary, energy intakes should be lower than energy expenditure during the early phase (4-7 days) and are increased to match energy expenditure later.

The macro-and micronutrient content of EN differs between various formulations. While isocaloric EN (1 kcal/ml) is commonly prescribed to achieve estimated or measured caloric goals [52] [53] [54] , energy-dense formulae (> 1 kcal/ml) are also available. The increase in energy is achieved with increases in the proportion of mainly factor, carbohydrate.

The most common reasons for prescribing an energydense formulation are either to increase calorie delivery in patients with gastrointestinal dysfunction, an inability to tolerate full-volume isocaloric EN, fluid restriction or transitioning to oral nutrition using an intermittent-feeding schedule (e.g., overnight) while ensuring adequate energy intake. However, several caveats exist.

First, higher osmolality and fat content in energydense formulations may further impair delayed gastric emptying via neurohumoral feedback mechanisms (e.g., cholecystokinin, glucagon-like peptide-1) and via duodenal osmoreceptors which decrease gastric emptying until the gastric and duodenal contents are iso-osmotic. These solutions might cause diarrhea via the stimulation of fluid secretion within the small intestine [55] . Finally, the delivery of energy-dense nutrition at a lower rate may have the unintended consequence of decreased water and protein administration.

Second, the early administration of an energy-dense formulation has not been shown to improve outcomes. A large study reported that a near 50% increase in calorie delivery with an energy-dense EN formulation did not improve mortality at any time point, organ support or 6-month quality of life and functional outcomes compared to a 1 kcal/ml formulation [36, 40] . Subgroup analysis also did not demonstrate any differences between the energy-dense and isocaloric EN groups. Energy-dense EN was associated with increased gastrointestinal intolerance and higher blood glucose levels.

Patients' muscle mass at ICU admission is correlated with ICU survival and this serves as an endogenous metabolic or amino acid reserve [4, 8, 56, 57] (Fig. 1) . The catabolic response leads to marked muscle mass loss of up to 1 kg per day over the first 10 days of ICU stay and is associated with ICU-Acquired Weakness [58] . Nitrogen losses increase fourfold within the first 24 h of ICU stay [59] .

Current data consistently demonstrate that ICU patients receive low amounts of protein (average of 0.6 g/ kg/day for the first two weeks) [24, [60] [61] [62] [63] [64] [65] [66] [67] . Higher protein provision is associated with reduced mortality in adults in observational trials [61, [68] [69] [70] [71] [72] [73] [74] , biochemical outcome parameters and morphometric outcomes in skeletal muscle [75] [76] [77] [78] [79] , improved quality of life at 3-month post-ICU [69] or handgrip strength at hospital day 7 and muscle mass [73] . However, prospective studies show limited effects on clinical, patient-centered and functional outcomes or yield negative results [45, 67, [74] [75] [76] [77] [78] [79] [80] [81] . Admittedly, a limited number of large RCTs examined clinical outcomes of specifically increasing protein administration.

Hence, there is no evidence for a higher protein intake in critically ill patients in terms of clinically relevant outcomes in prospective randomized trials [82, 83] . Moreover, some harm can be related to excessive amounts of proteins in a post hoc analysis of prospective trials performed in adults [45, 84, 85] or in children [86] and in a retrospective study [87] . Hence, it may be prudent to start protein delivery at a lower dose (~ 0.8 g/kg) and ramp up protein dose to the targeted protein goal (> 1.2-1.3 g/kg/day [6, 7] (Fig. 2) . However, this strategy was not previously evaluated in prospective studies.

The role of high-protein intakes that stress the need for focused larger clinical trial evidence examining the effect of specifically increasing protein delivery [4, 67, 84] , combined with active mobilization to optimize physical therapy and functional outcomes in long-stayers, requires further study. Importantly, muscle volume and strength are not necessarily related. Preliminary data suggest that the combination of neuromuscular electrical Adapted from: CHUV Lausanne and Gelderse Vallei Hospitals. The X axis represents the time from admission (days, arbitrary example) and the Y axis the percentage of nutritional goal determined by a computer protocol using sex, height, weight (first 3 days) and later by indirect calorimetry or calculation prioritizing the avoidance of energy overfeeding. Regular (hourly) checks of intakes including the amount of non-nutritional energy (propofol, glucose, citrate) are recommended to adapt the infusion rate. Multi-micronutrients are administered IV until the dietary recommended intakes are met by the EN solution. The screening for refeeding syndrome is based on daily phosphate determination from day 2. In case of hypophosphatemia (hypoP) (serum phosphate (PO4) < 0.65 mmol/l, or a drop from baseline > 0.16 mmol/l occurring within 72 h of the start of EN) decrease the amount of energy delivered to a maximum of 500 kcal/day, supplement phosphate, magnesium (Mg) and potassium (K) and additional boluses of thiamine (vit B1, 500-1000 mg IV) stimulation and high-protein supplementation (1.8 g/kg/ day) significantly improved short physical performance [88] . The role of high-dose protein delivery and in-bed ergometry (cycling) is being meaningfully studied [89] (NCT03021902).

There now exist a range of available high protein-toenergy ratio products intended to meet protein targets and non-protein calorie goals with a limited risk of overfeeding of non-protein calories. The use of enteral protein supplements or supplemental amino acid solutions (such as clear liquid whey protein formulas) is proposed for this purpose [90] . However, it is important to keep the amino acid composition well balanced. Nutrition regimens that are grossly unbalanced inflict a metabolic strain on the patient [91] . A high-protein product may be used in the later stable phase of critical illness [85] . However, there are no data from prospective randomized controlled studies with clinically relevant outcomes to support this recommendation.

Some potential alternatives include the addition of the leucine metabolite HMB (hydroxy methyl butyrate) to improve amino acid metabolism and reduce net protein breakdown [92] .

A high-nitrogen intake should always be accompanied by daily monitoring of plasma concentration of urea and creatinine together with base excess. If plasma urea concentration is increasing, urea excretion in urine should be identified and followed by a decrease of protein intake and eventually renal replacement therapy. If base excess increases, always consider reducing protein intake. Acidosis may come in critically ill patients for several reasons, but when the renal compensatory mechanisms are overridden will the ability to eliminate a surplus of nitrogen be impaired.

Ingestion of micronutrients (MN), i.e., trace elements and vitamins, is essential for normal metabolism [93] , immunity [94] , and antioxidant defense. They work as a web, and 24 of them are "essential," meaning that nutrition is the only source. The body stores of MNs are variable but generally insufficient to ensure normal metabolism beyond one week. The MNs needs will depend on the presence of prior deficiency, food intake before admission, particular body fluid losses, disease, and feeding rate. The available feeding products are meant to cover the needs of healthy people (dietary reference intakes) provided about 1500 kcal/day is delivered to the patients [95] . However, these amounts are not integrating the specific requirements of critically ill patients. Intestinal function and absorption are often absent or depressed during the first days, and antioxidant stress is maximal [96] .

Further, most recent guidelines [7] recommend that EN is started within 48 h of admission after stabilization [5] and progressed to target over 3-4 days (Fig. 2) . Consequently, MN delivery starts at close to zero and remains below DRI for nearly a week, or "forever" in patients receiving less than 1500 kcal. It has been proposed to measure blood concentrations of some MN at risk [15] . The results of analysis are often not timely available and may be costly. As most patients stay briefly (< 5 days), there is no time to adapt to a delayed abnormal result. Nevertheless, blood values determination is rational for selected MNs depending on pathology and treatment when the patients stay more than a week, especially when renal replacement therapy is required [97] [98] [99] [100] [101] .

Critically ill patients are often admitted with a nutritional deficit developed in the days preceding ICU admission, translating into MN deficiencies. The earliest manifestation is refeeding syndrome (RFS), with thiamine being in the first line discussed below [105] . The late complications are less specific, generally unrecognized, and sometimes called an "invisible foe" [110, [102] [103] [104] [105] . Infections and wound healing complications are in the first line as MN are essential for immune defense. Therefore, during the early phase, as EN cannot cover the everyday needs and the higher needs associated with critical illness, early intravenous delivery of doses like those used in PN is rational (1 vial multitrace element and multivitamin + 100-200 mg thiamine) (Fig. 2) . A few trials have shown that the strategy to deliver MNs intravenously at doses 4-5 times higher than for PN until EN can cover the needs is associated with better global outcomes [106, 107] .

Refeeding syndrome (RFS) is a potentially fatal acute metabolic response following the reintroduction of nutrients after a variable length of starvation that may lead to morbidity and increased mortality [108] .

Refeeding syndrome is characterized by electrolyte shifts that arise from a switch from a catabolic state using fat and protein as energy sources back to carbohydrate metabolism. Glucose substrate utilization leads to increased insulin levels, resulting in thiamine depletion and low plasma levels of phosphate, magnesium and potassium due to the intracellular shift of electrolytes [109] [110] [111] . The complications of RFS are so severe that the liberal administration of intravenous thiamine 100-200 mg/day for the first 3 days should be part of routine (Fig. 2) . In the absence of appropriate management, many clinical potentially life-threatening consequences may develop [108] .

Due to significant variations in RFS definitions, its exact incidence remains unknown. However, when RFS is defined by hypophosphatemia (hypoP) with a cut-off level of 0.65 mmol/L, the incidence ranges from 34 to 40%, with 4-10% presenting severe hypophosphatemia (phosphate < 0.32 mmol/L) or a drop after the start of glucose infusion or nutrition therapy [111] [112] [113] . Most recent studies in ICU patients using hypoP as the primary criterion to define RFS did not identify clinical predictors of RFS on ICU admission [41, 110, 114] . Therefore, all critically ill patients should be considered at risk of refeeding syndrome and monitored for serum phosphate levels at least once a day when starting EN [110] . The diagnostic criteria and recommendations to monitor phosphate have recently been adopted by the ESPEN nutrition guidelines [7] .

Recent studies have demonstrated that high-energy intake during RFS is associated with increased mortality, and caloric restriction confers improved outcomes [114, 115] . The difference in mortality occurred much later during patients' ICU stay after correction of electrolyte imbalance, suggesting a complex pathophysiology [41, 114] . Thiamine administration and caloric restriction of 500 kcal/day or 25% of the estimated target inspired from NICE guidance [116] is a frequent practice for ICU patients with hypoP/RFS for at least 48 h.

Practical protocols are available on-line (e.g., [117]) to guide progressing energy to target in the early phase of ICU stay is provided. Energy target on admission is based on predictive equations. In 4 steps of 25%, feeds are advanced to the estimated target to prevent overfeeding, including non-nutritional energy from propofol and citrate. Indirect calorimetry is performed to adjust to the actual energy expenditure and set as a new target. When refeeding hypoP within 72 h after the start of EN is encountered, caloric restriction is warranted. After 48 h subsequently, the following steps (25%) are set.

Gastrointestinal (in)tolerance is often defined with certain symptoms/signs, with 'tolerance' meaning the absence of these symptoms and signs [118] [119] [120] . 'Enteral feeding intolerance' (EFI) is commonly defined as a certain amount of gastric residual volumes (GRV) [119] [120] [121] , capturing only upper gastrointestinal (GI) problems after initiation of enteral tube feeding, while both upper and lower parts of the GI tract can be involved (Fig. 3) . In most of available studies, patients with EFI were more severely ill compared to patients tolerating EN, suggesting that EFI could be an epiphenomenon or a marker of disease severity [118] .

In several studies, the occurrence of EFI as a feature of GI dysfunction was shown to independently associate with adverse outcome, as an additional organ dysfunction [119, [121] [122] [123] [124] .

Gastric intolerance assessed by the GRV measurement is the prevalent gastrointestinal symptom in ICU patients treated with EN [118, 125, 126] . Measurements of GRV have been omitted in many sites since a study showed no benefit of GRV-guided EN in patients with already established EN despite vomiting occurred more often in patients without than with GRV measurements [127] . However, the relation of GRV with the tracheal aspiration of gastric contents and pneumonia development is not clear [128, 129] and GRV measurement is a timeconsuming practice and is associated with infectious risk (COVID-19) and variability in practices [121, 122] . Due to these factors and uncertainties, recent guidelines either do not recommend routine measurement of GRV [6] , or suggest restricting GRV measurements to the initiation and progression of EN only [5, 7] . The latter is important, as evidence from RCTs is available only for medical patients having full EN already established at study inclusion [126] . Moreover, there is no good substitute for GRV, which could be considered as a surrogate marker of gastric emptying at bedside [128] . Therefore, depending on local constraints, GRV can still be included in assessment of EFI and a GRV over 500 ml/6 h is considered as an indication for intervention (delay or interruption of EN or application of prokinetics) [129] . [5, 7, [130] [131] [132] [133] , even though prokinetics has not been proven to improve patient-relevant outcomes [134] .

Lower parts of GI tract are often involved, even in the absence of upper GI intolerance. Lower GI intolerance requires different management. Bowel paralysis leading to bowel distension in patient receiving EN may be associated with adverse outcomes. Patients in shock receiving early full EN compared to PN more often developed Ogilvie's syndrome and bowel ischemia [22] . Monitoring and management of EFI and GI dysfunction is complicated due to the lack of robust and reproducible markers and multifaceted clinical presentation [49] . As no single straightforward marker reliably detects GI dysfunction, using composite scores combining several symptoms and signs could be helpful and should be considered [131] . EFI at the bedside is defined as features of GI dysfunction appearing during EN and consequently leading to reduction or discontinuation of EN. [123, 124, 135] Evidence on management options, unanswered issues and proposals for future research on GI dysfunction have been recently summarized [136] . In brief, patients should be carefully assessed for high gastric residual volume (optional-threshold 500 ml/6 h), vomiting, pain, distension, elevated/increasing intra-abdominal pressure, GI paralysis.

The importance of medical nutrition in the care of the critically ill cannot be overstated. Overall, the management of EN requires a systematic and updated approach involving all ICU professionals, including practical approaches proposed in this document and regular updates. Auditing changes in practice are needed locally from the entire community of ICU professionals to increase the safety and efficiency of the delivery of EN.

Authors' contributions JCP drafted the conception and design of this article, YMA drafted Sects. 1 and 2, SMC drafted Sect. 3, MC and GVdB drafted Sect. 4, SP drafted Sect. 5, PW and JW drafted Sects. 6 and 7, MB and AvZ drafted Sects. 8 and 9, and ARB and JCM drafted Sect. 10. All authors critically revised the manuscript and brought significant contributions to all sections. All authors read and approved the final manuscript.

None.

Not applicable.

Ethical approval and consent to participate Not applicable.

Not applicable. Screening for enteral feeding intolerance (ARB). Differentiation between EFI in different parts of GI tract and respective terminology has not been uniformly established. *Suggested contraindications to EN are uncontrolled shock, uncontrolled hypoxemia and acidosis, uncontrolled upper GI bleeding, gastric aspirate > 500 ml/6 h, bowel ischemia, bowel obstruction, abdominal compartment syndrome, and high-output fistula without distal feeding access. # GRV between 200 and 500 ml can be considered increased and > 500 ml a cut-off for discontinuation of EN

Nutrition evaluation and management of critically ill patients with COVID-19 during post-intensive care rehabilitation

ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection

Metabolic and nutritional support of critically ill patients: consensus and controversies

Metabolic support in the critically ill: a consensus of 19

Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines

Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN)

ESPEN guideline on clinical nutrition in the intensive care unit

Metabolic response to the stress of critical illness

The 2016 ESPEN Arvid Wretlind lecture: the gut in stress

Parenteral nutrition is associated with intestinal morphologic and functional changes in humans

Delayed enteral feeding impairs intestinal carbohydrate absorption in critically ill patients

Early enteral nutrition preserves intestinal barrier function through reducing the formation of neutrophil extracellular traps (NETs) in critically ill surgical patients

Early enteral nutrition provided within 24 hours of ICU admission: a meta-analysis of randomized controlled trials

Early enteral nutrition (within 48 h) versus delayed enteral nutrition (after 48 h) with or without supplemental parenteral nutrition in critically ill adults

Monitoring nutrition in the ICU

Enteral nutrition should not be given to patients on vasopressor agents

Enteral nutrition can be given to patients on vasopressors

Intestinal absorption in patients after cardiac surgery

Bowel necrosis associated with early jejunal tube feeding: a complication of postoperative enteral nutrition

Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection

Muzevich KM Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy

NUTRIREA-2 trial investigators; clinical research in intensive care and sepsis (CRICS) group. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)

Impact of the route of nutrition on gut mucosa in ventilated adults with shock: an ancillary of the NUTRI-REA-2 trial

Trial of the route of early nutritional support in critically ill adults

Phase 3 pilot randomized controlled trial comparing early trophic enteral nutrition with "no enteral nutrition" in mechanically ventilated patients with septic shock

Design of the study of early enteral dextrose in sepsis: a pilot placebocontrolled randomized clinical trial

Enteral nutrition as stress ulcer prophylaxis in critically ill patients: a randomized controlled exploratory study

Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline

Enteral nutrition better than proton pump inhibitors?

Multidisciplinary practical guidelines for gastrointestinal access for enteral nutrition and decompression from the Society of Interventional Radiology and American Gastroenterological Association (AGA) Institute, with endorsement by Canadian Interventional Radiological Association (CIRA) and Cardiovascular and Interventional Radiological Society of Europe (CIRSE)

Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults

Comparisons between intragastric and small intestinal delivery of enteral nutrition in the critically ill: a systematic review and meta-analysis

Enteral tolerance in critically ill patients

One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial

Physical and cognitive performance of acute lung injury patients one year after initial trophic vs full enteral feeding: EDEN trial follow-up

Outcomes six months after delivering 100% or 70% of enteral calorie requirements during critical illness (TARGET): a randomized controlled trial

Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial

Permissive underfeeding and intensive insulin therapy in critically ill patients : a randomized controlled trial

Permissive underfeeding or standard enteral feeding in critically ill adults

Energy-dense versus routine enteral nutrition in the critically ill

Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial

Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool

Permissive underfeeding or standard enteral feeding in high and low nutritional risk critically ill adults: post-hoc analysis of the permit trial

TICACOS international: a multicenter, randomized, prospective controlled study comparing tight calorie control versus Liberal calorie administration study

Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, outcome assessor-blinded EAT-ICU trial

Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial

Indirect Calorimetry: a faithful guide for nutrition therapy, or a fascinating research tool?

The clinical potential of GDF15 as a "ready-to-feed indicator" for critically ill adults

What happens to nutrition intake in the post-intensive care unit hospitalization period? An observational cohort study in critically ill adults

Nutrition rehabilitation in the intensive care unit

Enteral nutrition in Australia and New Zealand intensive care units: a point-prevalence study of prescription practices

Nutrition therapy in Australia and New Zealand intensive care units: an international comparison study

Management of nutrition in European intensive care units: results of a questionnaire. Working group on metabolism and nutrition of the European Society of Intensive Care Medicine

Energy-dense formulae may slow gastric emptying in the critically ill

Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients

Promoting perioperative metabolic and nutritional care

Acute skeletal muscle wasting in critical illness

Protein and aminoacid metabolism: stress versus nonstress states

Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients

The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study

Protein intake, nutritional status and outcomes in ICU survivors: a single center cohort study

A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial

Adequate nutrition may get you home: effect of caloric/protein deficits on the discharge destination of critically ill surgical patients

Protein provision in critically ill adults requiring enteral nutrition: are guidelines being met?

Review of evolution and current status of protein requirements and provision in acute illness and critical care

High protein intake during the early phase of critical illness: yes or no?

Optimal protein and energy nutrition decreases mortality in mechanically ventilated, critically ill patients

The association between nutritional adequacy and long-term outcomes in critically ill patients requiring prolonged mechanical ventilation: a multicenter cohort study

Clinical outcomes related to protein delivery in a critically ill population

Greater protein and energy intake may be associated with improved mortality in higher risk critically ill patients: a multicenter

Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study

Close to recommended caloric and protein intake by enteral nutrition is associated with better clinical outcome of critically ill septic patients: secondary analysis of a large international nutrition database

Provision of protein and energy in relation to measured requirements in intensive care patients

Appropriate protein provision in critical illness: a systematic and narrative review

Dose-response relationship between protein intake and muscle mass increase: a systematic review and meta-analysis of randomized controlled trials

Protein requirements in the critically ill: a randomized controlled trial using parenteral nutrition

Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome

High-protein hypocaloric vs normocaloric enteral nutrition in critically ill patients: a randomized clinical trial

Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Protein delivery and clinical outcomes in the critically ill: a systematic review and meta-analysis

Systematic review with meta-analysis of patient-centered outcomes, comparing international guideline-recommended enteral protein delivery with usual care

Early versus late parenteral nutrition in critically ill adults

Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis

Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial

Timing of PROTein INtake and clinical outcomes of adult critically ill patients on prolonged mechanical VENTilation: The PROTINVENT retrospective study

Neuromuscular electrical stimulation and high-protein supplementation after subarachnoid hemorrhage: a single-center phase 2 randomized clinical trial

Nutrition and Exercise in Critical Illness Trial (NEXIS Trial): a protocol of a multicentred, randomised controlled trial of combined cycle ergometry and amino acid supplementation commenced early during critical illness

Nutrition therapy and critical illness: practical guidance for the ICU, post-icu, and long-term convalescence phases

A randomized trial of glutamine and antioxidants in critically ill patients

Impact of β-hydroxy-βmethylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: a RCT

Functions and deficiency states of trace elements and vitamins

Review of micronutrients and the immune system-working in harmony to reduce the risk of infection

Micronutrient deficiencies in medical and surgical inpatients

Feeding mitochondria: potential role of nutritional components to improve critical illness convalescence

Trace element and vitamin deficiency: quantum medicine or essential prescription?

Nutrition disorders during acute renal failure and renal replacement therapy

Nutrients and micronutrients at risk during renal replacement therapy: a scoping review

Metabolic and nutritional characteristics of long-stay critically ill patients

Monitoring and parenteral administration of micronutrients, phosphate and magnesium in critically ill patients: The VITA-TRACE Survey

Recovery after critical illness: putting the puzzle together-a consensus of 29

Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline

Scanning for new evidence to prioritize updates to the dietary reference intakes: case studies for thiamin and phosphorus

Micronutrient deficiency in critical illness: an invisible foe?

Antioxidant supplements modulate clinical course after complex cardiac surgery-preliminary data

Oxidative stress

Nutritional support and refeeding syndrome in critical illness

Is refeeding syndrome relevant for critically ill patients?

Refeeding syndrome relevance for the critically ill patient

Electrolyte disorders during the initiation of nutrition therapy in the ICU. Curr Opin Clin Nutr Metab Care

Hypophosphatemia in critically ill adults and children-a systematic review

Prevalence of hypophosphatemia in the ICU-results of an international one-day point prevalence survey

research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year submit your research ? Choose BMC

Refeeding Syndrome Trial Investigators Group. Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial

Refeeding syndrome: what it is, and how to prevent and treat it

Gastrointestinal dysfunction and feeding intolerance do we need an objective scoring system?

Definition, prevalence, and outcome of feeding intolerance in intensive care: a systematic review and meta-analysis

When and how to manage enteral feeding intolerance?

Incidence, risk factors, and clinical consequence of enteral feeding intolerance in the mechanically ventilated critically ill: an analysis of a multicenter

Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness

Severity of acute gastrointestinal injury grade is a predictor of all-cause mortality in critically ill patients: a multicenter, prospective, observational study

Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM working group on abdominal problems

Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study

Gastric residual volume in critically ill patients: a dead marker or still alive?

Effect of not monitoring residual gastric volume on risk of ventilatorassociated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial

Correlation between gastric residual volumes and markers of gastric emptying: a post hoc analysis of a randomized clinical trial

Gastric residual volume during enteral nutrition in ICU patients: the REGANE study

Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients

Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients-a prospective multicenter observational study (iSOFA study)

Monitoring for intolerance to gastric tube feedings: a national survey

Gut function in the intensive care unit-What is "normal

The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials

Enteral feeding intolerance: updates in definitions and pathophysiology

Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the section of metabolism, endocrinology and nutrition of the European Society of Intensive Care Medicine

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations